BMS Scoops Cormorant In $520M Immuno-Oncology Deal

 
• By Mike Ward
  
Maarten de Château
Maarten de Château, CEO of Cormorant Pharmaceuticals • Source: Cormorant Pharmaceuticals AB
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip